# Epintek Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epintek-biotechnology

- Industry: Healthcare IT
- Headquarters: Guiyang, China
- Latest round: Series A (Apr 11, 2024)
- Investors on record: 3

## About

Based in Guiyang, Chia, and founded in 2023, Epintek Biotechnology operats as a CDMO (Contract Development and Manufacturing Organization) service provider that focuses on the medical device CDMO business. It is a subsidiary of Epintek. In April 2024, the company closed a series A funding led by new investor Guiyang Venture Capital, with participation from other new investors Guiyang Health and Wellness Investment and Guiyang Baiyun Industry.

Epintek Biotechnology mainly provides CDMO services for medical aesthetics, gels, catheters, IVD reagents and other products, and has developed a medical device CRTDMO integrated service platform. The company also provides medical device companies with cooperative R&D, supply chain management, commissioned production, device inspection and testing, animal testing, clinical trials, product registration and other services.

Epintek Biotechnology generates revenue by providing CDMO outsourcing services.

Epintek Biotechnology will accelerate construction of CDMO platform for passive medical devices.

## Funding rounds

- Series A, Apr 11, 2024 — Guiyang Venture Capital, Guiyang Health and Wellness Investment, Guiyang Baiyun Industry

## Investors

- Guiyang Venture Capital (https://capitalatlas.ai/funds/guiyang-venture-capital) — Series A
- Guiyang Health and Wellness Investment — Series A
- Guiyang Baiyun Industry — Series A